TCM
CRTX

Touradji Capital Management’s CORNERSTONE THERAPEUTICS INC CRTX Stock Holding History

Touradji Capital Management’s Portfolio CRTX Stock Details CRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-21,500
Closed -$204K – 64
2013
Q4 		$204K Buy
21,500
+5,000
+30% +$47.3K 0.77% 47
2013
Q3 		$155K Buy
16,500
+5,000
+43% +$45.1K 0.48% 52
2013
Q2 		$92K Buy
+11,500
New +$96.9K 0.34% 55

Other funds holding CRTX

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Touradji Capital Management's CRTX Position: Q1 2014 in Review

Touradji Capital Management sold out of CORNERSTONE THERAPEUTICS INC (CRTX) in Q1 2014, closing a stake of 21,500 shares — an estimated $204K sold.

Touradji Capital Management first reported a position in CRTX in Q2 2013 and held it in 3 quarters. The position peaked at $204K in Q4 2013. 1 fund tracked by Wall St. Rank holds CRTX as of Q1 2014.

  • Touradji Capital Management reported no remaining CORNERSTONE THERAPEUTICS INC position as of Q1 2014 after selling out during the quarter.
  • Touradji Capital Management sold 21,500 CORNERSTONE THERAPEUTICS INC shares in Q1 2014, an estimated $204K.
  • Touradji Capital Management first reported a position in CORNERSTONE THERAPEUTICS INC in Q2 2013 and held it in 3 quarters.
  • Touradji Capital Management's CORNERSTONE THERAPEUTICS INC position peaked at $204K in Q4 2013.
  • 1 fund tracked by Wall St. Rank held CORNERSTONE THERAPEUTICS INC as of Q1 2014.

Based on Touradji Capital Management's 13F filing for Q1 2014, filed 5 May 2014.